ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 20 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142 | +10.9% | 12,445 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $128 | +33.3% | 12,445 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $96 | +5.5% | 12,445 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $91 | -99.9% | 12,445 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $90,000 | -15.1% | 12,445 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $106,000 | -5.4% | 12,445 | 0.0% | 0.01% | +10.0% |
| Q1 2022 | $112,000 | -22.8% | 12,445 | +19.1% | 0.01% | -28.6% |
| Q4 2021 | $145,000 | +30.6% | 10,445 | 0.0% | 0.01% | +27.3% |
| Q3 2021 | $111,000 | +18.1% | 10,445 | 0.0% | 0.01% | +22.2% |
| Q2 2021 | $94,000 | -15.3% | 10,445 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $111,000 | -15.9% | 10,445 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $132,000 | +43.5% | 10,445 | 0.0% | 0.02% | +25.0% |
| Q3 2020 | $92,000 | -81.2% | 10,445 | -79.3% | 0.01% | -82.1% |
| Q2 2020 | $490,000 | +1.4% | 50,445 | -69.9% | 0.07% | -1.5% |
| Q1 2020 | $483,000 | -32.2% | 167,588 | -9.6% | 0.07% | -8.1% |
| Q4 2019 | $712,000 | -3.1% | 185,287 | -0.2% | 0.07% | -6.3% |
| Q3 2019 | $735,000 | +43.8% | 185,587 | +52.9% | 0.08% | +43.6% |
| Q2 2019 | $511,000 | -39.5% | 121,363 | -1.3% | 0.06% | -37.5% |
| Q1 2019 | $844,000 | +86.3% | 122,972 | 0.0% | 0.09% | +72.5% |
| Q4 2018 | $453,000 | – | 122,972 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,056,420 | $22,006,000 | 19.85% |
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $48,300,000 | 17.51% |
| GREAT POINT PARTNERS LLC | 3,448,521 | $24,829,000 | 5.98% |
| Omega Fund Management, LLC | 2,029,580 | $14,613,000 | 5.35% |
| Paradigm Biocapital Advisors LP | 2,214,722 | $15,946,000 | 2.13% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $21,497,000 | 1.66% |
| COMMODORE CAPITAL LP | 1,325,000 | $9,540,000 | 1.53% |
| Octagon Capital Advisors LP | 1,225,000 | $8,820,000 | 1.52% |
| RA Capital Management | 4,356,632 | $31,368,000 | 0.67% |
| TCG Crossover Management, LLC | 254,569 | $1,833,000 | 0.55% |